forex signal system trading: There's a new leader in the projected $180 billion vaccine race (Details inside)

You are receiving this as a part of your subscription to The Startup Investor. To remove your email from this list, unsubscribe here.

Dear Startup Investor,

For a whole month, I've been telling you about this "dark horse" vaccine candidate...

This company has been researching coronaviruses for OVER two years...
They were one of the first in the world to successfully test a COVID vaccine on animals...
And since April 6, they've been testing this new vaccine on humans.

The entire world has been eagerly awaiting these test results for months.

And I'm excited to finally announce...

We expect to have ALL of this critical information within the next few days.

Specifically, by June 30...

Which is likely why the company's share price has been going HAYWIRE.

Hedge funds, state departments, and even billionaires like Bill Gates are pouring truckloads of capital into the nearly $5 billion firm.

And considering this experimental vaccine could rake in $180 billion...

There is a TON of room for this stock to grow.

And we're expecting these clinical trial results - which could come any time before June 30 - to be the tipping point.

That's why you absolutely CANNOT hesitate here...

Not even until after the weekend.

If you want to invest in what could be the world's first approved COVID vaccine...

Then you must act right now.

We're looking at potential gains of 3,000% or more when it's all said and done.

Go here, and you'll see everything you need to know.

Sincerely,

Bob Keppel
Publisher, The Startup Investor

Please do not reply to this email. It was sent from an unmonitored mailbox.

You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: unsubscribe here.

To cancel, or for any other questions or requests, please contact our Customer Service team:
Online
Phone: 866-310-1498 (North America) 410-501-5876 (International)
Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET.

© 2020 Angels & Entrepreneurs. All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.

We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201.

Website | Privacy Policy | Terms & Conditions

There's a new leader in the projected $180 billion vaccine race (Details inside)

No comments:

Post a Comment